Sequencing hope

DNA sequencing is the foundation for biological advancements by enabling the exploration of genetic variants and structural changes in DNA. Consequently, demand for large-scale genomics has skyrocketed.

Gencove developed a new technology - a hardware-agnostic, high-throughput, and cost-effective sequencing software-as-a-service. Powered by Gencove’s platform, academic institutions, clinical laboratories, and companies across agriculture and pharma can now seamlessly access complete genomic information with ease.

Learn More >

Our Team

Geoff benton
Geoff Benton, Ph.D.
Chief Executive Officer
Chase mazur
Chase Mazur
Director of Finance & Operations
Tati rodriguez
Tatiana Rodriguez
Director of Commercial Strategy & Partnerships
Mislav cimpersak
Mislav Cimpersak
Director of Engineering
Flagel
Lex Flagel, Ph.D.
Director of Data Science
Miguelheadshot1
Miguel Liezun
Senior Software Engineer
IMG 3979 1
Forest Dussault
Senior Software Engineer
GB headshot 2025
Gillian Belbin
Senior Data Scientist

Board of Directors

Geoff benton
Geoff Benton, Ph.D.
Chief Executive Officer
Sara eshelman
Sara Eshelman
Spero Ventures
Alex dickinson
Alex Dickinson, Ph.D.
Independent
Lily034821 1
Lily Reed
Lewis & Clark Partners
Tom Crow Headshot
Tom Crow
Lewis & Clark Partners
Gencove workers doing sequencing

Are you motivated by contributing to a healthier and more sustainable civilization?

We are biologists, geneticists, data scientists, engineers, and business leaders working with our customers, to help develop a software-based genomic technology to advance global health and sustainability.

View open roles >

Gencove is backed by world-class investors

3k
Alexandria
Lewisandclark
Burstcapital
Spero
Techammer
Versionone
Refactor
Svangel
Syndicatefund